137th Day Of Lockdown

Maharashtra49026232728117092 Tamil Nadu2850242275754690 Andhra Pradesh2069601204641842 Karnataka164924842322998 Delhi1427231282324082 Uttar Pradesh113378668341981 West Bengal89666630601954 Bihar7179446294400 Gujarat68855517922604 Assam5549737225132 Rajasthan4941835186763 Odisha4255028698292 Haryana4005433444467 Madhya Pradesh3729827621962 Kerala3170019147103 Jammu and Kashmir2392716218449 Punjab2193014040539 Jharkhand165427503154 Chhatisgarh11408831987 Uttarakhand89015731112 Goa7947559570 Telangana751354330615 Tripura6014408437 Puducherry5123291475 Manipur3466192610 Himachal Pradesh3206200813 Nagaland26578247 Arunachal Pradesh204913263 Chandigarh137482023 Meghalaya10234236 Sikkim8544061 Mizoram5672890
Science 25 May 2019 Virtual Reality can ...

Virtual Reality can better detect early Alzheimer's

ANI
Published May 25, 2019, 5:19 pm IST
Updated May 25, 2019, 5:19 pm IST
VR could also help clinical trials of future drugs aimed at slowing down, or even halting progression of Alzheimer's disease.
The researchers took samples of cerebrospinal fluid (CSF) to look for biomarkers of underlying Alzheimer's disease in their MCI patients, with 12 testing to be positive.
 The researchers took samples of cerebrospinal fluid (CSF) to look for biomarkers of underlying Alzheimer's disease in their MCI patients, with 12 testing to be positive.

Virtual reality can better detect early Alzheimer's than the 'gold standard' tests, a new study suggested.

The findings of the study were published in the journal Brain.

 

"These results suggest a VR test of navigation may be better at identifying early Alzheimer's disease than tests we use at present," said Dr Dennis Chan, lead researcher.

A key component of this internal satnav is a region of the brain known as the entorhinal cortex. This is one of the first regions to be damaged in Alzheimer's disease, which may explain why 'getting lost' is one of the first symptoms of the disease.

Researchers developed and tried a VR navigation test in which patients wear a VR headset and undertake a test of navigation while walking within a simulated environment. Successful completion of the task requires intact functioning of the entorhinal cortex.

 

The team recruited 45 patients with mild cognitive impairment (MCI). Patients with MCI typically exhibit memory impairment, but while MCI can indicate early Alzheimer's, it can also be caused by other conditions such as anxiety and even normal ageing.

The researchers took samples of cerebrospinal fluid (CSF) to look for biomarkers of underlying Alzheimer's disease in their MCI patients, with 12 testing to be positive. The researchers also recruited 41 age-matched healthy controls for comparison.

All of the patients with MCI performed worse on the navigation task than the healthy controls. However, the study yielded two crucial additional observations.

 

First, MCI patients with positive CSF markers - indicating the presence of Alzheimer's disease, performed worse than those with negative CSF markers at low risk of future dementia.

Secondly, the VR navigation task was better at differentiating between these low and high-risk MCI patients than a battery of currently-used tests considered to be the gold standard for the diagnosis of early Alzheimer's.

VR could also help clinical trials of future drugs aimed at slowing down or even halting the progression of Alzheimer's disease.

 

Dr Chan explained, "We know that Alzheimer's affects the brain long before symptoms become apparent."

He added, "We live in a world where mobile devices are almost ubiquitous, and so app-based approaches have the potential to diagnose Alzheimer's disease at minimal extra cost and at a scale way beyond that of brain scanning and other current diagnostic approaches."

Click on Deccan Chronicle Technology and Science for the latest news and reviews. Follow us on Facebook, Twitter

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT